Additional benefit of induced pluripotent stem cell-derived mesenchymal stem cell therapy on sepsis syndrome-associated acute kidney injury in rat treated with antibiotic

BACKGROUND: This study tested whether human induced-pluripotent stem-cell-derived mesenchymal-stem-cells (iPS-MSCs) would offer an additional benefit to the rodent with acute kidney injury (AKI) (ischemia for 1 h followed by reperfusion for 120 h) associated sepsis syndrome (SS) (by cecal-ligation-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chih-Chao, Sung, Pei‐Hsun, Chen, Chih-Hung, Chiang, John Y., Shao, Pei-Lin, Wu, Shun-Cheng, Yip, Hon‐Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499569/
https://www.ncbi.nlm.nih.gov/pubmed/34620235
http://dx.doi.org/10.1186/s13287-021-02582-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499569/
https://www.ncbi.nlm.nih.gov/pubmed/34620235
http://dx.doi.org/10.1186/s13287-021-02582-5

Ejemplares similares